The discovery is the first milestone of a program by the partners to develop a panel of protein biomarkers they plan to use in clinical trials to develop treatments for the disease.
Under the terms of the agreement, Bio-Rad will have the right to develop the HBP marker for use on its proprietary laboratory instruments globally. Additional terms of the deal were not disclosed.
The company said that it will work with BMS to investigate the utility of its technology for diagnosis of Alzheimer's disease and for identifying individuals with early-stage cognitive impairment that are likely to progress to Alzheimer's disease.
Under its contract with SAIC-Frederick, Epitomics will develop high affinity and renewable agents to capture tryptic peptides derived from human plasma protein biomarkers.
Seoul Clinical Laboratories will distribute the firm's OvPlex diagnostic panel in South Korea after the firm received market clearance from the South Korea Food and Drug Administration.
Researchers from Stanford University and Lucile Packard Children's Hospital used a gene expression-based proteomics method to find protein biomarkers associated with acute organ transplant rejection.
